Your session is about to expire
← Back to Search
N-Acetylcysteine for Myeloproliferative Disorders
Study Summary
This trial is testing a possible new treatment for blood cancer using a drug called N-acetylcysteine. They are trying to find the best dose of the drug to give to patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowExclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 3 trial • 302 Patients • NCT01675661Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Dose Level 1 (DL1)
- Group 2: Dose Level 2 (DL2)
- Group 3: Dose Level 3 (DL3)
Frequently Asked Questions
What pathologies is N-Acetylcysteine typically employed to ameliorate?
"N-Acetylcysteine is frequently utilized to treat corneal ulceration, acute rhinitis, acetaminophen poisoning and other ocular conditions."
To what extent has the capacity of this study been reached?
"Unfortunately, this research is not currently accepting participants. It was first published on March 1st of 2022 and last modified 20 days later. If you are interested in additional studies, there are 2540 trials for polycythemia vera that still have openings as well as 38 clinical investigations into N-Acetylcysteine recruiting volunteers."
Are there any prior studies that have employed N-Acetylcysteine as a therapeutic agent?
"Currently, there are 38 investigations into N-Acetylcysteine underway with 7 initiatives in the advanced Phase 3. 44 distinct medical sites have research programs for this compound, several of which are situated in New york City."
Are recruitment efforts still underway for this research endeavor?
"According to data hosted on clinicaltrials.gov, the trial is not currently accruing patients as recruitment had ceased since January 20th 2022. However, there are 2578 other studies where patient enrolment is taking place at present."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger